David E. Clark began his career at Proteus Molecular Design, where he was involved in developing software for de novo ligand design and protein-ligand docking. He then worked in the CADD group of Aventis/Rhône-Poulenc Rorer before joining Argenta (acquired by Charles River in 2014) as a founding scientific member. Dr. Clark studied chemistry at the University of Oxford, then carried out his postgraduate studies at the Department of Information Studies at the University of Sheffield. In 2003, he was the recipient of the Corwin Hansch award, which is presented annually by the QSAR and Modelling Society.
- Frozen! Cryo-EM Grabs the Limelight (Eureka Blog)
- 1 in 800 Million: A DNA Tool That Screens Drug Compounds in Big Way (Eureka Blog)
- Clarity for CLL Patients? (Eureka Blog)
- Knee Deep in the Hoopla (Eureka Blog)
- Passing on the Baton in the Race to End Malaria (Eureka Blog)
- Two for the Price of One (Eureka Blog)
- Facing Down the World’s Deadliest Animal (Eureka Blog)